Status: Recruiting
Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors
A Phase 1 clinical trial to evaluate the safety and early efficacy of CAR T-cells with IL-7Ra signal targeting B7H3 in children with solid tumors patients after complete standard treatments.
Participants needed: 9
Trial details
Phase: Phase 1Age: 1-25Biological sex: AllType: InterventionalSponsor: Chulalongkorn UniversityUpdated: Mar 2, 2026Locations: 1
Eligibility criteria
Participants must have B7-H3 positive solid tumor with measurable disease. [+17]
Presence of greater than or equal to grade 3 cardiac dysfunction or symptomatic... [+4]